mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |